GALDERMA LABS LP FDA Approval NDA 019737

NDA 019737

GALDERMA LABS LP

FDA Drug Application

Application #019737

Documents

Letter2002-06-03

Application Sponsors

NDA 019737GALDERMA LABS LP

Marketing Status

Prescription001

Application Products

001GEL;TOPICAL0.75%1METROGELMETRONIDAZOLE

FDA Submissions

TYPE 3; Type 3 - New Dosage FormORIG1AP1988-11-22PRIORITY
MANUF (CMC); Manufacturing (CMC)SUPPL2AP1989-01-19PRIORITY
MANUF (CMC); Manufacturing (CMC)SUPPL3AP1989-06-20PRIORITY
MANUF (CMC); Manufacturing (CMC)SUPPL4AP1990-05-15PRIORITY
MANUF (CMC); Manufacturing (CMC)SUPPL5AP1994-03-24PRIORITY
LABELING; LabelingSUPPL6AP1995-08-21STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL7AP2002-06-04PRIORITY

Submissions Property Types

ORIG1Orphan5
SUPPL2Null14
SUPPL3Null14
SUPPL4Null14
SUPPL5Null14
SUPPL7Null14

TE Codes

001PrescriptionAB

CDER Filings

cder:Array
(
    [0] => Array
        (
            [ApplNo] => 19737
            [companyName] => 
            [docInserts] => ["",""]
            [products] => []
            [labels] => 
            [originalApprovals] => []
            [supplements] => 
            [actionDate] => 0000-00-00
        )

)

© 2026 FDA.report
This site is not affiliated with or endorsed by the FDA.